Condition
Acute Treatment of Migraine clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Acute Treatment of Migraine clinical trials that are recruiting, at sites in 5 countries (most in United States (3), Poland (1), Spain (1)). By phase: Phase 4 (2), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Acute Treatment of Migraine clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Rimegepant 75 mg ODT for acute migraine in adults in India | Phase 4 | Visakhapatnam, Andhra Pradesh and 6 other locations | Recruiting | Jul 6, 2026 |
| Second dose of rimegepant for acute migraine in adults | Phase 4 | Canoga Park, California and 23 other locations | Recruiting | May 27, 2026 |
| Zavegepant (nasal spray) for treating migraine in children 6 to under 12 | Phase 1 | Washington D.C., District of Columbia and 13 other locations | Recruiting | May 29, 2025 |
| Long-term safety of rimegepant for treating migraines in children | Phase 3 | Scottsdale, Arizona and 123 other locations | Recruiting | Feb 8, 2021 |
All recruiting trials (4)
-
Rimegepant 75 mg ODT for acute migraine in adults in India
A single-arm study in adults in India will test whether a 75 mg orally disintegrating tablet of rimegepant is safe to use for treating a migraine attack when triptans didn’t work or can’t be used.
-
Second dose of rimegepant for acute migraine in adults
This study tests whether taking a second 75 mg dose of rimegepant is safe and tolerable for adults who still have pain after an initial dose to treat an acute migraine attack.
-
Zavegepant (nasal spray) for treating migraine in children 6 to under 12
This trial will test a single weight-based dose of zavegepant nasal spray to see how safe it is and how the medicine is processed in children 6 to under 12 with migraine.
-
Long-term safety of rimegepant for treating migraines in children
This study is testing the long-term safety of rimegepant, a migraine medication, for children and teens aged 6 to under 18 who have frequent migraine attacks.
Quick answers
How many Acute Treatment of Migraine clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), Poland (1 trial), Spain (1 trial), Israel (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.